Zimmer Biomet Holdings Inc
Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates as a medical technology company worldwide. The company designs, manufactures, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; craniomaxillofacial and thoracic products comprising face and skul… Read more
Market Cap & Net Worth: Zimmer Biomet Holdings Inc (ZBH)
Zimmer Biomet Holdings Inc (NYSE:ZBH) has a market capitalization of $18.49 Billion ($18.49 Billion) as of March 18, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #1060 globally and #820 in its home market, demonstrating a -0.86% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Zimmer Biomet Holdings Inc's stock price $93.30 by its total outstanding shares 198181555 (198.18 Million).
Zimmer Biomet Holdings Inc Market Cap History: 2015 to 2026
Zimmer Biomet Holdings Inc's market capitalization history from 2015 to 2026. Data shows growth from $18.41 Billion to $18.49 Billion (0.49% CAGR).
Index Memberships
Zimmer Biomet Holdings Inc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$53.10 Trillion | 0.05% | #368 of 503 |
Weight: Zimmer Biomet Holdings Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Zimmer Biomet Holdings Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Zimmer Biomet Holdings Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.73x
Zimmer Biomet Holdings Inc's market cap is 2.73 times its annual revenue
0.67x
Higher than industry averageLatest Price to Earnings (P/E) Ratio
23.16x
Zimmer Biomet Holdings Inc's market cap is 23.16 times its annual earnings
1.97x
Higher than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $18.41 Billion | $6.00 Billion | $147.00 Million | 3.07x | 125.20x |
| 2016 | $18.67 Billion | $7.67 Billion | $305.90 Million | 2.44x | 61.05x |
| 2017 | $22.01 Billion | $7.80 Billion | $1.81 Billion | 2.82x | 12.13x |
| 2018 | $19.08 Billion | $7.93 Billion | -$379.20 Million | 2.41x | N/A |
| 2019 | $27.74 Billion | $7.98 Billion | $1.13 Billion | 3.48x | 24.51x |
| 2020 | $28.78 Billion | $6.13 Billion | -$138.90 Million | 4.70x | N/A |
| 2021 | $23.88 Billion | $6.83 Billion | $401.60 Million | 3.50x | 59.47x |
| 2022 | $24.92 Billion | $6.94 Billion | $231.40 Million | 3.59x | 107.67x |
| 2023 | $23.97 Billion | $7.39 Billion | $1.02 Billion | 3.24x | 23.41x |
| 2024 | $20.93 Billion | $7.68 Billion | $903.80 Million | 2.73x | 23.16x |
Competitor Companies of ZBH by Market Capitalization
Companies near Zimmer Biomet Holdings Inc in the global market cap rankings as of March 18, 2026.
Key companies related to Zimmer Biomet Holdings Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #79 globally with a market cap of $190.05 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #153 globally with a market cap of $121.18 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #169 globally with a market cap of $112.92 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #191 globally with a market cap of $103.18 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #79 | Abbott Laboratories | NYSE:ABT | $190.05 Billion | $109.95 |
| #153 | Stryker Corporation | NYSE:SYK | $121.18 Billion | $349.56 |
| #169 | Medtronic PLC | NYSE:MDT | $112.92 Billion | $88.24 |
| #191 | Boston Scientific Corp | NYSE:BSX | $103.18 Billion | $69.79 |
Zimmer Biomet Holdings Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Zimmer Biomet Holdings Inc's market cap moved from $18.41 Billion to $ 18.49 Billion, with a yearly change of 0.49%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $18.49 Billion | +3.76% |
| 2025 | $17.82 Billion | -14.87% |
| 2024 | $20.93 Billion | -12.65% |
| 2023 | $23.97 Billion | -3.81% |
| 2022 | $24.92 Billion | +4.32% |
| 2021 | $23.88 Billion | -17.02% |
| 2020 | $28.78 Billion | +3.77% |
| 2019 | $27.74 Billion | +45.37% |
| 2018 | $19.08 Billion | -13.30% |
| 2017 | $22.01 Billion | +17.86% |
| 2016 | $18.67 Billion | +1.46% |
| 2015 | $18.41 Billion | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of Zimmer Biomet Holdings Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $18.49 Billion USD |
| MoneyControl | $18.49 Billion USD |
| MarketWatch | $18.49 Billion USD |
| marketcap.company | $18.49 Billion USD |
| Reuters | $18.49 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.